TAK

Takeda Pharm

• TipRanks·1d ago

  Takeda Deepens Its Rare Disease Data Moat With New AATD Liver Study

• TipRanks·1d ago

  Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK

• PUBT·2d ago

  Abivax names new global heads of marketing, sales and market access in commercial leadership shake-up

• Reuters·3d ago

  AI shortens drug discovery to around 1 year in China, Insilico CEO says

• PUBT·3d ago

  Takeda says China approves ORZEYFUL orexin agonist for narcolepsy type 1

• TipRanks·5d ago

  Takeda dengue vaccine receives marketing authorization from India DCGI

• Benzinga·07/17 17:08

  Oral Psoriasis Drug From Takeda Demonstrates Strong Skin Clearance in Trials

• Benzinga·07/17 14:19

  Reported July 16: Takeda Announces New Data From Two Phase 3 Studies Of Zasocitinib In Adults With Plaque Psoriasis; Secondary Endpoint Data Indicate Consistent And High Rates Of Skin Clearance

• Reuters·07/16 22:04

  TAKEDA PHARMACEUTICAL CO - NO NEW SAFETY SIGNALS IDENTIFIED FOR ZASOCITINIB THROUGH WEEK 24

• Reuters·07/16 22:04

  TAKEDA PHARMACEUTICAL CO - 75% OF SCALP PSORIASIS PATIENTS ACHIEVE CLEAR OR ALMOST CLEAR SKIN WITH ZASOCITINIB AT WEEK 16

• TipRanks·07/16 16:30

  Takeda’s TAK-226 Anemia Trial Offers New Optionality in Hematology

• Seeking Alpha·07/16 04:52

  Nvidia CEO Huang visits Japan, unveils AI partnerships across key industries

• PUBT·07/16 04:30

  Siegfried names Eduardo Montanha COO, effective Sept. 1

• TipRanks·07/15 16:32

  Takeda Extends TAK-360 Sleep Trial, Signaling Long-Term Ambitions in Narcolepsy

• TipRanks·07/14 16:30

  Takeda’s Takhzyro Real‑World Pediatric Study Wraps Up, Setting the Stage for Next Moves